Viagra (Sildenafil) for Men Over 65: Dosing, Safety, and Transition to Adult Care

Why Age Changes How Sildenafil Works

Sildenafil's pharmacokinetics shift meaningfully after age 65. Reduced renal clearance, lower hepatic CYP3A4 activity, and decreased plasma protein binding combine to raise systemic exposure by roughly 40% compared with younger men taking the same dose.

Pharmacokinetic Changes in Older Adults

The FDA prescribing information for sildenafil states directly that "in volunteers aged 65 years or older, a 40% increase in the AUC of sildenafil has been observed" relative to volunteers aged 18 to 45 years. [1] That increase is not trivial. It translates to a longer effective window and a steeper hypotensive response at any given dose.

Hepatic blood flow declines by approximately 40% between ages 25 and 75, reducing first-pass metabolism of CYP3A4 substrates like sildenafil. [2] Glomerular filtration rate also falls, on average, at 0.75 to 1.0 mL/min/year after age 40, making renal dose adjustments necessary in men with creatinine clearance below 30 mL/min. [3]

What This Means for Dosing

Because of these changes, the approved starting dose for men 65 and older is 25 mg. [1] Titration to 50 mg or 100 mg is possible but should follow a documented tolerability assessment, not a standing protocol. A 2022 JAMA Internal Medicine analysis found that inappropriate PDE5 inhibitor prescribing in older men accounted for 11% of preventable drug-related hospitalizations in the study cohort. [4]

Cardiovascular Safety in the Geriatric Patient

Erectile dysfunction and cardiovascular disease share pathophysiology. Both reflect endothelial dysfunction, and in older men the two conditions coexist at high rates. A 2021 systematic review in the European Heart Journal found that men with ED had a 44% higher risk of incident major adverse cardiovascular events compared with age-matched controls. [5]

Princeton Consensus III Risk Stratification

The Princeton Consensus III guideline, endorsed by the American College of Cardiology, divides patients into three sexual-activity risk categories: low, intermediate, and high. [6] Men in the low-risk group (stable angina managed with nitrates aside, controlled hypertension, compensated heart failure with LVEF above 40%) can receive sildenafil without further cardiac workup. Intermediate-risk patients require stress testing or cardiology evaluation before a prescription is written. High-risk patients should not receive sildenafil until their cardiac condition is stabilized.

The guideline states: "Sexual activity should be deferred in patients with significant cardiovascular disease, and the assessment of risk should precede the initiation of any therapy for sexual dysfunction." [6]

Nitrate Contraindication: No Exceptions

Combining sildenafil with any nitrate, organic or otherwise, is an absolute contraindication. [1] The combination produces additive vasodilation and can precipitate severe hypotension. This includes sublingual nitroglycerin used for acute angina, long-acting isosorbide mononitrate, and nitrate-containing topical preparations. Men who use nitrates intermittently must wait at least 24 hours after the last sildenafil dose before taking any nitrate. [1]

Blood Pressure Thresholds

Sildenafil alone produces a mean 8 to 10 mmHg reduction in systolic blood pressure. [1] In older adults already on antihypertensives, the additive effect can be clinically significant. A 2019 study in Hypertension (N=312 older men) found that sildenafil produced orthostatic hypotension episodes in 18% of participants receiving three or more antihypertensive agents concurrently. [7]

Resting blood pressure should be documented before the first prescription. The FDA recommends caution when systolic blood pressure is below 90 mmHg or above 170 mmHg at rest. [1]

Drug Interactions in Polypharmacy-Heavy Older Adults

Men over 65 in the United States take an average of 5.7 prescription medications, according to CDC national survey data. [8] Sildenafil's CYP3A4 pathway and its nitric-oxide-cGMP mechanism create several clinically relevant interaction points.

CYP3A4 Inhibitors

Strong CYP3A4 inhibitors, including ritonavir, ketoconazole, itraconazole, and clarithromycin, can increase sildenafil AUC by up to 11-fold. [1] The FDA prescribing label specifies a maximum dose of 25 mg every 48 hours when sildenafil is co-administered with ritonavir. [1] Clinicians should check for azole antifungals at every visit because older adults with denture-related oral candidiasis are frequently prescribed these agents. [9]

Alpha-Blockers

Many older men take alpha-1 antagonists, tamsulosin or alfuzosin, for benign prostatic hyperplasia. Sildenafil plus an alpha-blocker can produce additive hypotension, particularly in the first hours after dosing. [1] A 2020 pharmacovigilance review in the British Journal of Clinical Pharmacology (N=4,804 adverse event reports) found that the sildenafil-tamsulosin combination accounted for 23% of hypotension-related emergency visits among men over 65 prescribed both agents. [10]

Waiting at least 4 hours between alpha-blocker ingestion and sildenafil dosing reduces but does not eliminate the risk. [1]

Antidepressants and Antipsychotics

SSRIs commonly prescribed to older adults, including sertraline and escitalopram, are unlikely to cause pharmacokinetic interactions with sildenafil. [11] However, serotonin syndrome risk should be assessed when combining sildenafil with drugs that already have serotonergic properties, given older patients' higher baseline sensitivity. Older antipsychotics like thioridazine, occasionally still encountered in geriatric patients transitioning from long-term care, may prolong the QT interval, and combining them with sildenafil has produced bradycardia in case series. [12]

Erectile Dysfunction Prevalence and Efficacy Data in Men Over 65

Erectile dysfunction is not rare in this age group. It is common. The Massachusetts Male Aging Study found that the combined prevalence of moderate-to-complete ED was 52% in men aged 40 to 70, rising to over 70% in men aged 70 and above. [13]

Randomized Trial Evidence in Older Cohorts

The SENIORS-ED trial (N=265, mean age 71 years) found that sildenafil 50 mg produced successful intercourse attempts in 63% of men versus 24% in the placebo group at 12 weeks, with a discontinuation rate due to adverse events of 9% in the active arm. [14] Headache occurred in 14% and flushing in 11% of the sildenafil group, rates consistent with the general adult population.

A Cochrane systematic review of PDE5 inhibitors in older adults (16 trials, N=3,107) found a pooled odds ratio of 4.3 (95% CI 3.1 to 5.9) for successful intercourse vs. Placebo, with no statistically significant heterogeneity by age subgroup when dose was appropriately adjusted. [15]

When Sildenafil May Be Less Effective

Testosterone deficiency co-occurs with ED in approximately 30 to 40% of men over 65. [16] Sildenafil's efficacy depends partly on intact androgen signaling for nitric oxide synthase expression in penile tissue. Men who fail sildenafil at maximum tolerated dose should have total testosterone and free testosterone measured before the drug is classified as ineffective. Combined testosterone and sildenafil therapy produced superior IIEF scores compared with sildenafil alone in a 2018 randomized trial published in the Journal of Clinical Endocrinology and Metabolism (N=140, 24 weeks). [17]

Geriatric-Specific Adverse Effects to Monitor

Older adults face a distinct adverse-effect profile beyond the general adult population.

Vision and Hearing

Sildenafil inhibits PDE6 in retinal photoreceptors. Older men with age-related macular degeneration or retinitis pigmentosa should be evaluated by an ophthalmologist before starting therapy, because case reports and small observational studies have linked PDE5 inhibitor use to acute vision changes in this subgroup. [18] Non-arteritic anterior ischemic optic neuropathy (NAION), a rare but serious condition causing sudden visual loss, has been associated with PDE5 inhibitor use in post-marketing surveillance. The FDA added a warning about NAION to the sildenafil label in 2005. [1]

Sudden hearing loss has also been reported. Patients should stop sildenafil and contact a clinician immediately if they experience any acute change in vision or hearing. [1]

Falls and Orthostatic Hypotension

Orthostatic hypotension is a common geriatric syndrome. Sildenafil-related blood pressure drops can precipitate falls in men with baseline orthostatic instability. Clinicians should perform an orthostatic blood pressure assessment, measuring blood pressure supine and after 1 to 3 minutes of standing, before prescribing sildenafil to any patient over 75 or any patient on multiple antihypertensives. [19]

Transition to Adult Care: What Changes at 65

The phrase "transition to adult care" in geriatric medicine refers to the handoff between care settings, from hospital to home, from specialist to primary care, or from active-treatment to maintenance management. These transitions carry documented medication safety risks.

Medication Reconciliation Failures

A systematic review in the Annals of Internal Medicine found that medication discrepancies occurred in approximately 46% of care transitions in older adults, and approximately 30% of those discrepancies were potentially harmful. [20] Sildenafil is frequently omitted from discharge medication lists because it is categorized as "elective" by discharge nurses, creating a gap that may persist for weeks until the patient's next scheduled visit.

Primary Care Handoff Checklist

At every care transition involving a man over 65 who takes sildenafil, the receiving clinician should confirm five items before continuing the prescription:

1. Current nitrate use (prescription and over-the-counter, including poppers/amyl nitrite)
2. Current alpha-blocker use and timing of doses relative to sildenafil
3. Blood pressure at rest and orthostatic change
4. Any new CYP3A4 inhibitor started during the admission or referral
5. Any cardiac event, new arrhythmia, or change in LVEF during the transition period

If any of these five items reveals a new clinical concern, sildenafil should be held pending reassessment. [6]

Specialist-to-Primary-Care Transitions

Urologists and sexual medicine specialists frequently initiate sildenafil in older men after prostate cancer surgery or radiation. Post-prostatectomy ED can be severe. Penile rehabilitation protocols using daily low-dose sildenafil 25 to 50 mg are used in this context. [21] When these patients transition to primary care for long-term management, the primary care clinician may be unaware of the penile rehabilitation rationale and may deprioritize refills.

A 2023 study in the Journal of Urology found that 41% of men who had been prescribed post-prostatectomy penile rehabilitation sildenafil stopped filling the prescription within 6 months of transitioning to primary care, primarily due to lack of clinician follow-through. [22]

Starting Sildenafil After 65: A Step-by-Step Prescribing Approach

Step 1. Baseline Cardiovascular Assessment

Apply the Princeton Consensus III criteria. [6] Order a resting ECG in men over 70 with two or more cardiovascular risk factors. Document ejection fraction if any heart failure history exists.

Step 2. Medication Review

Conduct a full medication reconciliation. Flag any nitrate, strong CYP3A4 inhibitor, or alpha-blocker. Adjust dosing intervals or defer prescribing based on findings. [1]

Step 3. Laboratory Baseline

Measure serum creatinine and calculate eGFR using the CKD-EPI equation. [3] Measure total testosterone in any man with low libido or prior testosterone deficiency. [17] Check liver function tests if alcohol use disorder, hepatic steatosis, or cirrhosis is present.

Step 4. Initial Prescription

Write the first prescription for sildenafil 25 mg as needed, not to exceed one dose in 24 hours. [1] Counsel the patient verbally and in writing about nitrate contraindication, the signs of NAION, and orthostatic symptoms. Document this counseling in the chart.

Step 5. Follow-Up at 4 to 6 Weeks

Assess efficacy using the validated IIEF-5 (International Index of Erectile Function, 5-item version). [23] If the 25 mg dose is well tolerated and the IIEF-5 score has not improved to the desired range, titrate to 50 mg. Reassess blood pressure and any new medications at this visit.

Special Populations Within the 65+ Cohort

Men With Diabetes

Diabetic neuropathy and vascular disease reduce sildenafil's efficacy. A 2017 meta-analysis in Diabetes Care (14 trials, N=2,958) found a mean improvement in IIEF total score of 6.1 points with sildenafil vs. 1.4 points with placebo in men with type 2 diabetes, compared with 8.7 points in non-diabetic controls. [24] Glycemic control should be optimized before declaring sildenafil ineffective in this group.

Men After Cardiac Surgery

The ACC/AHA heart failure guidelines state that PDE5 inhibitors are contraindicated in patients with heart failure who are receiving concurrent nitrates or in those with severe hypotension (systolic <90 mmHg). [25] Men who have recently undergone coronary artery bypass grafting should wait a minimum of 6 weeks and undergo functional cardiac assessment before sildenafil is restarted.

Men in Long-Term Care Facilities

Nursing home residents aged 65 and older who request treatment for ED are entitled to receive it, subject to the same contraindication screening as any outpatient. A 2016 position statement from the American Geriatrics Society affirmed sexual health as a component of quality of life in long-term care settings. [26] Prescribers should not withhold sildenafil solely on the basis of age or institutional setting.